Pharmaceutical solutions & Specialty ingredients

About SEQENS in 2022

Our main activities

A leader in
Pharmaceutical synthesis

A strong expertise in
Specialty Ingredients

A complete and integrated
R&D offer

Committed to developing
and sustainably producing

Newsroom

#Live

Events / General

Seqens Group Opens Flagship Pharmaceutical R&D Center in Boston

The Seqens group has announced today that it has opened a state-of-the-art, 1,500 sqm R&D center in Devens, Mass., to serve as one…
Read more
General

Seqens group at DCAT Week 2023

From March 20 to 23, 2023, a delegation representing all the group’s pharmaceutical activities attended the DCAT week in New York. More than a…
Read more
General

Seqens chooses to reshore Paracetamol production in France : work on the future plant has begun.

Back in June 2020, Emmanuel Macron announced his will to restore France’s health sovereignty. Following this, Seqens has chosen to reshore a part of…
Read more
See all news

Join the Seqens team!

Joining Seqens is a unique opportunity to participate in an exciting growth project with a strong international dimension and a strong entrepreneurial spirit.

Seqens global presence

Use interactive map
0

Employees

0

Scientists, experts and engineers

0

Manufacturing sites

0

Customers in more than 80 countries